Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Launch of CSR programme

13 Mar 2012 07:00

RNS Number : 2001Z
Cello Group plc
13 March 2012
 



13 March 2012

 

Cello Group plc

 

Launch of CSR programme

 

Cello Group plc (AIM:CLL, 'Cello', or 'the Group'), the insight and strategic marketing group, has today launched its new Corporate Social Responsibility programme 'Talking Taboos'. 

 

Talking Taboos is a campaigning brand that aims to directly tackle health and social issues using Cello's experience and resources in the healthcare space. It will focus on areas where embarrassment, fear or ignorance prevents sufferers from seeking help.

 

For 2012, Talking Taboos will be addressing teen mental health, specifically self-harm, through an extensive research project with the teen charity YoungMinds. The research will examine the context in which teenagers find themselves when actively self-harming, and will attempt to inform parents, teachers, peers and health professionals how best to identify and support at-risk and self-harming teens.

Each Cello Group company will utilise its expertise in methodology or market sector to contribute to a 'whole community' view that will help carers and sufferers by providing context, exploding myths and challenging prevailing attitudes to self-harm. The programme is being led by Vincent Nolan, Group Chairman of Cello Research and Consulting, and the Group is planning to expand this initiative in the future to assist organisations which address a range of health related issues.

Mark Scott, Cello Group CEO, said:

 

"Talking Taboos is a great opportunity for us to support a worthwhile cause in the best way we know how - through our market leading research and our wealth of experience in working with health issues.

 

"It is also an ideal way for our companies to demonstrate their abilities and talents and work across the group to deliver a comprehensive project that should help change the way that self-harm is perceived and handled."

 

 

Enquiries:

 

Cello Group plc (www.cellogroup.com)

Mark Scott, Chief Executive

020 7812 8460

Mark Bentley, Group Finance Director

Vincent Nolan, Group Chairman - Cello Research and Consulting

020 7655 9900

Cenkos

Bobbie Hilliam

020 7397 8900

College Hill

Kay Larsen/Rozi Morris

020 7457 2020

 

 

Notes to Editors (www.cellogroup.com)

 

Cello is an insight and strategic marketing group.

 

The Group's strategy is to create value for shareholders by building an international research and consulting business able to advise blue chip clients globally, along with a marketing business capable of delivering world class solutions.

 

Cello has annualised revenues in excess of £130m, annualised gross profit in excess of £65m and employs over 700 professional staff.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGUUWWUPPGMP
Date   Source Headline
14th May 20137:00 amRNSBoard Appointment
14th May 20137:00 amRNSAGM STATEMENT
10th May 20132:28 pmRNSAdditional Listing/TVR
23rd Apr 20137:00 amRNSHolding(s) in Company
19th Apr 20137:00 amRNSFace Launches Pulsar TRAC
12th Apr 20131:03 pmRNSAnnual Report and Accounts 2012
9th Apr 20137:00 amRNSDirector/PDMR Shareholding
2nd Apr 201312:44 pmRNSHolding(s) in Company
27th Mar 201310:00 amRNSHolding(s) in Company
20th Mar 20137:00 amRNSDirector/PDMR Shareholding
13th Mar 20137:00 amRNSPreliminary Results for the Year Ended 31 Dec 2012
1st Mar 20137:00 amRNSTotal Voting Rights
28th Jan 20137:00 amRNSPre-close trading update
28th Jan 20137:00 amRNSAcquisition of Mash Health
19th Dec 20129:50 amRNSHolding(s) in Company
14th Nov 20127:00 amRNSHealthcare Seminar
1st Oct 201212:29 pmRNSShare Option Grants
20th Sep 20129:09 amRNSDirector/PDMR Shareholding
19th Sep 20122:13 pmRNSDividend Timetable
19th Sep 20127:01 amRNSCello's Talking Taboos
19th Sep 20127:00 amRNSInterim Results 2012
3rd Sep 20128:30 amRNSNotice of Interim results
12th Jul 20122:21 pmRNSShare Option Grants
11th Jul 20127:00 amRNSTrading update
1st Jun 20127:00 amRNSTotal Voting Rights
24th May 20127:00 amRNSAdditional listing / TVR
16th May 201210:07 amRNSResult of AGM
15th May 20127:00 amRNSAGM Statement
1st May 20127:00 amRNSAdditional Listing
17th Apr 20127:00 amRNSAnnual Financial Report
27th Mar 20127:00 amRNSHolding(s) in Company
14th Mar 20127:00 amRNSDirector/PDMR Shareholding
13th Mar 20127:00 amRNSLaunch of CSR programme
13th Mar 20127:00 amRNSFinal Results
24th Jan 201212:59 pmRNSNotice of Results
23rd Jan 20127:01 amRNSYear end trading update
21st Dec 20117:00 amRNSDirectorate Change
19th Dec 20117:00 amRNSChange of Adviser
1st Nov 201111:30 amRNSHolding in Company
18th Oct 20117:00 amRNSHolding in Company
4th Oct 20117:00 amRNSDirector/PDMR Shareholding
21st Sep 201110:30 amRNSDirector/PDMR Shareholding
10th Aug 201110:37 amRNSNotice of Results
13th Jul 20117:00 amRNSDirector/PDMR Shareholding
6th Jul 20117:00 amRNSTrading update
14th Jun 20117:00 amRNSShare Option Grants
3rd Jun 201110:10 amRNSTotal Voting Rights
26th May 20117:00 amRNSAnalyst and investor teach-in
17th May 20111:23 pmRNSResult of AGM
17th May 20117:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.